Daniel Lorrain

Founder at CONTINEUM THERAPEUTICS, INC.

Net worth: 2 M $ as of 2026-06-29

57 year

Health Technology

Consumer Services

Profile

Daniel S.
Lorrain is the founder of Contineum Therapeutics, Inc., founded in 2017, serving as Chief Scientific Officer since 2018.
Former jobs include Senior Director at Amira Pharmaceuticals, Inc. from 2005 to 2010, and Vice President-Biology at Inception Sciences, Inc. from 2016 to 2018.
Education includes an undergraduate degree conferred in 1991 and a doctorate conferred in 1997, both from the State University of New York at Buffalo.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CONTINEUM THERAPEUTICS, INC. CLASS A 0.44%	2026-07-08	145,312 ( 0.44% )	2 M $	2026-06-29

Daniel Lorrain active positions

Companies	Position	Start
CONTINEUM THERAPEUTICS, INC.	Founder	2017-05-08

All active positions of Daniel Lorrain

Former positions of Daniel Lorrain

Companies	Position	End
Inception Sciences, Inc. Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services	Director/Board Member	2018-01-09
Amira Pharmaceuticals, Inc. Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products	Director/Board Member	2010-10-31

See the detail of Daniel Lorrain's experience

Training of Daniel Lorrain

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Lorrain's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Amira Pharmaceuticals, Inc. Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products	Health Technology
State University of New York at Buffalo State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inception Sciences, Inc. Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services	Health Technology
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications	Health Technology